< Back to companies
Genefron (ג'ינפרון)

Genefron (ג'ינפרון)

Jerusalem, Israel

Genefron is developing and producing the next generation of personal diagnostics kits. Their promise, forever to be kept, is to center the patient, focus on patient needs, reduce patient suffering and direct the ultimate treatment for the fastest recovery possible. Clinical diagnosis and management has been long focused on clinical signs and symptoms of a patient in order to treat specific diseases. This practice led to pre-determined treatments named as “standard of care” for all patients suffering the same disease.

Share
Shareable draft
Get Involved in Genefron (ג'ינפרון)

Company Info

Founded
2011
Website
www.genefron.com/

Categories

Diagnostics

Disease Areas

Technologies

Diagnostic DevicesDiagnostic TestingBiotechnologyMolecular Diagnostics
Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Genefron (ג'ינפרון)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Genefron (ג'ינפרון)
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free